Biocon Ltd Share Price
(BIOCON)
₹311.85
as on 04:01PM, 25 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -10.47 % |
3 Month Return | -15.77 % |
1 Year Return | + 1.78 % |
Market Stats | |
Previous Close | ₹326.75 |
Open | ₹326.75 |
Volume | 43.26L |
Upper Circuit | ₹359.40 |
Lower Circuit | ₹294.10 |
Market Cap | ₹37,440.71Cr |
P/E Ratio
46.41
PEG Ratio
-13.98
Market Cap
₹37,440.71 Cr
P/B Ratio
2.91
EPS
10.81
Dividend Yield
0.19
Sector
Pharmaceuticals
ROE
0.97
based on 20 analysts
57.89%
Buy
15.79%
Hold
26.32%
Sell
Based on 20 analysts offering long term price targets for Biocon. An average target of ₹380.95
Source: S&P Global Market Intelligence
Biocon price forecast by 20 analysts
Upside of22.16%
High
₹452
Target
₹380.95
Low
₹260
Biocon target price ₹380.95, a slight upside of 22.16% compared to current price of ₹311.85. According to 20 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Biocon revenue growth forecast
Expected growth rate Q1, FY2027:39.62%
Forecast
Actual
Including amortisation and stock based compensations
Biocon EPS growth forecast
EPS estimate Q1, FY2027:52.93%
Forecast
Actual
Source: S&P Global Market Intelligence
Biocon Plans Major Fundraising Initiative - 23 Apr, 2025
Biocon Board Meeting to Discuss Fundraising Proposal - 20 Apr, 2025
Biocon Secures U.S. Launch for Yesafili Biosimilar - 15 Apr, 2025
Biocon Biologics Secures FDA Approval for Jobevne - 10 Apr, 2025
Biocon Pharma Issues Recall for Cholesterol Medication - 09 Apr, 2025
Biocon Faces Stock Drop Amid Fundraising and Tariff Concerns - 07 Apr, 2025
Biocon Board Approves Rs. 600 Crore Paper Issuance - 04 Apr, 2025
Leadership Change and Fundraising Plans at Biocon - 02 Apr, 2025
Biocon Biologics Secures Major UK Joint Venture Guarantees - 26 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -16.0 Cr → 25.1 Cr (in ₹), with an average increase of 163.8% per quarter
MF Holding Up
Mutual Funds have increased holdings from 8.58% to 8.77% in Mar 2025 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 3.64K Cr → 3.87K Cr (in ₹), with an average increase of 5.8% per quarter
Against Peers
In the last 1 year, Vimta Labs Ltd has given 105.8% return, outperforming this stock by 93.7%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 5.66% of holdings in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 60.64% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Vimta Labs Ltd has given 219.8% return, outperforming this stock by 234.0%
Price Dip
In the last 1 month, BIOCON stock has moved down by -6.2%
Retail Holding Down
Retail Investor have decreased holdings from 18.12% to 17.76% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 60.64% | 0.00 | |
Foreign Institutions | 5.66% | 0.00 | |
Mutual Funds | 8.77% | 0.00 | |
Retail Investors | 17.76% | 0.00 | |
Others | 7.17% | 0.00 |
Biocon in the last 5 years
Lowest (24.48x)
March 19, 2024
Today (46.41x)
April 25, 2025
Industry (55.10x)
April 25, 2025
Highest (118.86x)
September 27, 2018
Biocon Ltd’s net profit fell -96.2% since last year same period to ₹25.10Cr in the Q3 2024-2025. On a quarterly growth basis, Biocon Ltd has generated 256.88% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Biocon Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.64%.
Read More about DividendsBearish
Neutral
Bullish
Biocon Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹37,440.71 Cr | -2.83% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹1,59,612.98 Cr | 29.57% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,09,614.17 Cr | 31.63% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
HOLD | ₹23,855.08 Cr | -4.09% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
BUY | ₹1,23,234.30 Cr | 30.14% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Organisation | Biocon |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Biocon Ltd share price today stands at ₹311.85, Open: ₹326.75, Previous Close: ₹326.75, High: ₹328.4, Low: ₹308.45, 52 Week High: ₹404.7, 52 Week Low: ₹269.55.
Today's traded volume of Biocon Ltd(BIOCON) is 43.26L.
Today's market capitalisation of Biocon Ltd(BIOCON) is ₹37440.71Cr.
Biocon Ltd (BIOCON) share price is ₹311.85. It is down -22.94% from its 52 Week High price of ₹404.7
Biocon Ltd (BIOCON) share price is ₹311.85. It is up 15.69% from its 52 Week Low price of ₹269.55